Aridis Pharmaceuticals, Inc. (ARDS)

Aridis Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	3	22	29	56	38	35
Market Cap Growth	-76.79%	-22.63%	-48.54%	47.86%	7.86%	-65.98%
Enterprise Value	4	23	15	48	17	11
PE Ratio	-	-0.72	-0.68	-2.54	-1.30	-1.58
PS Ratio	0.13	-	-	55.65	36.83	12.66
PB Ratio	-0.16	-0.91	-2.03	-6.41	10.35	1.33
P/FCF Ratio	-0.21	-0.76	-1.22	-2.67	-4.52	-1.40
P/OCF Ratio	-0.21	-0.76	-1.25	-2.72	-4.61	-1.44
EV/Sales Ratio	0.20	-	-	48.14	16.38	3.87
EV/EBITDA Ratio	-8.24	-0.79	-0.33	-2.15	-0.58	-0.41
EV/EBIT Ratio	-5.54	-0.78	-0.33	-2.12	-0.57	-0.41
EV/FCF Ratio	-0.29	-0.80	-0.62	-2.31	-2.01	-0.43
Debt / Equity Ratio	-0.06	-0.25	-0.42	-0.08	0	0.09
Debt / EBITDA Ratio	-2.26	-0.21	-0.13	-0.03	-	-
Debt / FCF Ratio	-0.08	-0.21	-0.25	-0.03	-	-
Quick Ratio	0.03	0.17	0.61	0.38	1.10	4.89
Current Ratio	0.37	0.32	0.80	0.67	1.45	4.58
Asset Turnover	3.09	0	0	0.07	0.04	0.09
Interest Coverage	-869.00	-79.35	178.41	0	0	-57.42
Return on Equity (ROE)	2.69%	126.89%	299.65%	252.49%	-797.19%	-84.00%
Return on Assets (ROA)	-9.72%	-209.25%	-157.79%	-145.00%	-103.64%	-69.93%
Return on Capital (ROIC)	3.98%	165.69%	537.52%	281.21%	-799.97%	-91.65%
Earnings Yield	-24.99%	-138.78%	-147.63%	-39.38%	-77.01%	-63.35%
FCF Yield	-705.86%	-131.83%	-81.94%	-37.45%	-22.14%	-71.49%
Buyback Yield / Dilution	-111.44%	-52.77%	-34.06%	-8.40%	-168.80%	60.12%
Total Shareholder Return	-111.44%	-52.77%	-34.06%	-8.40%	-168.80%	60.12%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.